A new program supported by the University of Kentucky’s Center for Research on Violence Against Women (CRVAW) and Center for Clinical and Translational Science (CCTS) will provide seed funding for research projects that address violence against women.
This is the third time the CCTS has successfully competed for the prestigious Clinical and Translational Science Award (CTSA), with continuous funding since 2011 totaling $65.4 million.
During "UK at the Half" UK football game on Saturday, CCTS was recognized for their clinical research — which helps to improve health, with an emphasis on the Central Appalachian region.
He serves as director of the CCTS pilot program and principal investigator of the BIRCWH (Building Interdisciplinary Research Careers in Women's Health) program.
His book “The Great Influenza: The Story of the Deadliest Pandemic in History” was an NYT bestseller and named by the National Academies of Science as the year’s outstanding book on science or medicine.
The CCTS will host the acclaimed medical historian John M. Barry, author of "The Great Influenza: The Story of the Deadliest Pandemic in History," at the keynote panel of its 2021 Spring Research Days, to be held the afternoons of April 7 and 8.
The CCTS serves as the engine for UK's testing site of the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study ENSEMBLE 2, which is evaluating the safety and efficacy of a two-dose regimen of Janssen’s COVID-19 vaccine candidate.
